Lithium Treatment and Risk of Dementia

被引:187
作者
Kessing, Lars Vedel [1 ]
Sondergard, Lars [1 ]
Forman, Julie Lyng [2 ]
Andersen, Per Kragh [2 ]
机构
[1] Univ Copenhagen Hosp, Rigshosp, Dept Psychiat, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark
关键词
D O I
10.1001/archpsyc.65.11.1331
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: It has been suggested that lithium may have neuroprotective abilities, but it is not clear whether lithium reduces the risk of dementia. Objective: To investigate whether continued treatment with lithium reduces the risk of dementia in a nationwide study. Design: An observational cohort study with linkage of registers of all patients prescribed lithium and diagnosed as having dementia in Denmark from January 1, 1995, through December 31, 2005. Setting: We identified all patients treated with lithium in Denmark within community psychiatry, private specialist, and general practices and a random sample of 30% of the general population. Subjects: A total of 16 238 persons who purchased lithium at least once and 1 487 177 persons from the general population who did not purchase lithium. Main Outcome Measure: Diagnosis of dementia or Alzheimer disease during inpatient or outpatient hospital care. Results: Persons who purchased lithium at least once had an increased rate of dementia compared with persons not exposed to lithium (relative risk, 1.47; 95% confidence interval, 1.22-1.76). For persons who continued to take lithium, the rate of dementia decreased to the same level as the rate for the general population. The rate of dementia decreased early after the consumption of lithium tablets corresponding to 1 prescription (typically 100 tablets) and stayed at a low level, although with a slight increase according to the number of subsequent prescriptions. The association between the number of prescriptions for lithium and dementia was unique and different from the association between the number of prescriptions for anticonvulsants and dementia. All findings were replicated in subanalyses with Alzheimer disease as the outcome. Conclusions: Continued lithium treatment was associated with reduction of the rate of dementia to the same level as that for the general population. Methodological reasons for this finding cannot be excluded, owing to the nonrandomized nature of data.
引用
收藏
页码:1331 / 1335
页数:5
相关论文
共 27 条
[1]  
Andersen TF, 1999, DAN MED BULL, V46, P263
[2]   Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles [J].
Caccamo, Antonella ;
Oddo, Salvatore ;
Tran, Lana X. ;
LaFerla, Frank M. .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (05) :1669-1675
[3]  
Clayton D, 1993, STAT MODELS EPIDEMIO
[4]   Elders with epilepsy [J].
Collins, Nancy S. ;
Shapiro, Rita A. ;
Ramsay, R. Eugene .
MEDICAL CLINICS OF NORTH AMERICA, 2006, 90 (05) :945-+
[5]  
*DAN NAT BOARD HLT, MED PROD STAT
[6]   Does lithium therapy protect against the onset of dementia? [J].
Dunn, N ;
Holmes, C ;
Mullee, M .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2005, 19 (01) :20-22
[7]   A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? [J].
Fountoulakis, Konstantinos N. ;
Vieta, Eduard ;
Bouras, Constantin ;
Notaridis, Grigorios ;
Giannakopoulos, Panteleimon ;
Kaprinis, George ;
Akiskal, Hagop .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (02) :269-287
[8]   Lithium for prevention of Alzheimer's disease - Authors' reply [J].
Gattaz, W. F. ;
Forlenza, O. V. ;
Nunes, P. V. .
BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 :361-362
[9]  
Juel K, 1999, DAN MED BULL, V46, P354
[10]  
KELLER MB, 1983, AM J PSYCHIAT, V140, P689